To observe the clinical efficacy of Oculentis regional refractive multifocal intraocular lens implantation for high myopia with cataract.

The clinical data of 120 eyes of 80 cases of high myopia with cataract from Jun.2018 to Jun.2019 in Nanyang Ophthalmologic Hospital were analyzed retrospectively.All cases were divided into two groups.Sixty eyes of 40 cases underwent phacoemulsification and Oculentis regional refractive multifocal intraocular lens implantation were included as the clinical trial group and 60 eyes of 40 cases received phacoemulsification combined with Bausch & Lomb monofocal intraocular lens implantation at the same time were included as the control group.After 3 months of follow-up after operation, the efficacy between the two groups were compared.

At 3 months after operation, the difference of the uncorrected distant visual acuity between the two groups was not statistically significant(t=0.762, P=0.45). The intermediate and near visual acuity of the trial group were better than those of the control group (t=1.806, 1.673; P=0.033, 0.045). Refractive state of the trial group was superior to that of the control group, and the difference was statistically significant (t=0.221, P=0.034). Postoperative complications did not occur in the trial group.Only 1 case of posterior capsular opacification occurred in the control group.

Oculentis region refractive multifocal intraocular lens implantation can provide good near, intermediate and distant vision in the naked eye for high myopia with cataract.

Cataract, myopia, high; Lens, intraocular, refractive, multifocal, Oculentis, regional; Phacoemulsification